Literature DB >> 2173252

Metastases of malignant melanoma simulating soft tissue sarcoma. A clinico-pathological, light- and electron microscopic and immunohistochemical study of 21 cases.

P Lodding1, L G Kindblom, L Angervall.   

Abstract

Metastases of cutaneous malignant melanoma (MM) of ordinary type can resemble various types of soft tissue sarcoma light microscopically to a degree which has not been previously recognized. Twenty-one cases are described, in which the tumours were originally diagnosed as a soft tissue sarcoma. Seven tumours were predominantly of blue and spindle-cell, fascicular type, resembling malignant peripheral nerve sheath tumour and at times monophasic synovial sarcoma. Ten tumours which were of fascicular and predominantly storiform type, and included uni- and multi-nuleated pleomorphic cells resembled malignant fibrous histiocytoma. Due to the presence of multivacuolated lipoblast-like tumour cells, 2 of these 10 tumours resembled pleomorphic liposarcoma. One had a predominantly myxoid and hypocellular appearance and 5 additional tumours included such areas. The diagnoses were revised after ultrastructural examination with the demonstration of melanosomes in 13 of 16 studied cases and the immunohistochemical demonstration of positivity using anti-S-100 protein antibodies and the anti-melanoma antibody NKI/C3 in all cases. The anti-melanoma antibody HMB 45 gave a positivity in 9 of 21 cases. Light microscopically, sparse amounts of melanin were noted in 7 tumours using the Whartin-Starry technique. Eleven tumours occurred at sites close to major lymph node groups and in 9 of these cases, lymphoid tissue was associated with the tumours, suggesting that they represented lymph node metastases. Following a review of the patients' clinical histories and renewed clinical examination, primary cutaneous MM was demonstrated in 10 of 21 patients and in 1 case an MM in regression was detected. The origin of the 10 tumours without a detected primary is discussed, including the possibility of an overlooked primary, spontaneous regression of a primary and a de novo origin from lymph nodes and soft tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173252     DOI: 10.1007/BF01606026

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  45 in total

1.  MALIGNANT MELANOMA OF UNKNOWN PRIMARY ORIGIN.

Authors:  T DASGUPTA; L BOWDEN; J W BERG
Journal:  Surg Gynecol Obstet       Date:  1963-09

2.  Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma).

Authors:  J Conley; R Lattes; W Orr
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Malignant melanoma: the patient with an unknown site of primary origin.

Authors:  G H Baab; C M McBride
Journal:  Arch Surg       Date:  1975-08

5.  Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.

Authors:  R M Esclamado; A M Gown; A M Vogel
Journal:  Am J Surg       Date:  1986-10       Impact factor: 2.565

6.  Neurotropic melanoma. A variant of desmoplastic melanoma.

Authors:  R J Reed; D D Leonard
Journal:  Am J Surg Pathol       Date:  1979-08       Impact factor: 6.394

7.  Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin.

Authors:  L G Kindblom; P Lodding; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

8.  S-100 protein in granular cell tumors (granular cell myoblastomas).

Authors:  K Stefansson; R L Wollmann
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

9.  Diagnostic application of panels of antibodies in mucosal melanomas of the head and neck.

Authors:  S C Henzen-Logmans; C J Meijer; D J Ruiter; H Mullink; A J Balm; G B Snow
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

10.  A modified Warthin-Starry procedure at low pH for melanin.

Authors:  R L Warkel; L G Luna; E B Helwig
Journal:  Am J Clin Pathol       Date:  1980-06       Impact factor: 2.493

View more
  9 in total

1.  Could it still be malignant melanoma or just a poorly differentiated neoplasm?

Authors:  Manju Sood; Heather Le Cocq; Faisal Ali; Sharif Al-Ghazal
Journal:  BMJ Case Rep       Date:  2009-07-07

2.  Metastatic amelanotic melanoma with occult primary masquerading as sarcoma.

Authors:  Niyaz Ahmed; Ranjit Kumar Padhiari; Praveen G P; Vishnu Kurpad
Journal:  J Clin Diagn Res       Date:  2015-02-01

3.  Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma.

Authors:  J Cruz; J S Reis-Filho; J M Lopes
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

4.  Amelanotic Signet Ring Cell Melanoma Presenting as Breast Lump- A Diagnostic Conundrum.

Authors:  Prasath Sathiah; Debasis Gochhait; Subathra Adithan; Sandhya Umamahesweran; Priyadarshini Dehuri
Journal:  J Clin Diagn Res       Date:  2017-08-01

5.  Atypical fibroxanthoma.

Authors:  Akio Sakamoto
Journal:  Clin Med Oncol       Date:  2008-02-09

Review 6.  Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment?

Authors:  Adriana C H van Engen-van Grunsven; Heidi Kusters-Vandevelde; Patricia J T A Groenen; Willeke A M Blokx
Journal:  Front Med (Lausanne)       Date:  2014-10-31

7.  A rare case of intranodal hemorrhagic spindle cell tumor with amianthoid fibers presenting as a suspicious lump in the groin.

Authors:  Esra Nsour; Ali Al Khader
Journal:  Int J Surg Case Rep       Date:  2019-10-07

8.  Single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report.

Authors:  Apostolos S Gogakos; Dimitrios Paliouras; Christos Asteriou; Thomas Rallis; Achilleas Lazopoulos; Fotios Chatzinikolaou; Athanassios Zissimopoulos; Drosos Tsavlis; Katerina Tsirgogianni; Konstantinos Zarogoulidis; Konstantinos Porpodis; Kosmas Tsakiridis; Georgia Pitsiou; Ioannis Kioumis; Ilias Karapantzos; Chrysanthi Karapantzou; Nikos Sachpekidis; Paul Zarogoulidis; Nikolaos Barbetakis
Journal:  Onco Targets Ther       Date:  2016-01-18       Impact factor: 4.147

9.  Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients.

Authors:  Luuk J Schipper; Kim Monkhorst; Kris G Samsom; Linda J W Bosch; Petur Snaebjornsson; Hester van Boven; Paul Roepman; Lizet E van der Kolk; Winan J van Houdt; Winette T A van der Graaf; Gerrit A Meijer; Emile E Voest
Journal:  Cancers (Basel)       Date:  2022-01-16       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.